KV Pharmaceutical, Hologic amend Gestiva asset purchase agreement

KV Pharmaceutical Company ( KVa/KVb) today announced it has entered into an amendment to the existing asset purchase agreement with Hologic, Inc. to secure the full U.S. and worldwide rights to Gestiva(TM), subject to the terms and conditions set forth in the amendment. Upon approval by the U.S. Food and Drug Administration (the "FDA"), Gestiva(TM) will be the first and only FDA-approved treatment for the prevention of preterm birth in women who are pregnant with a single baby and have spontaneously delivered a single baby preterm in the past. A description of certain material terms and conditions of the amendment to the existing asset purchase agreement with Hologic, Inc. is set forth in the Current Report on Form 8-K filed by the Company today with the SEC.

David Van Vliet, interim CEO at KV Pharmaceutical Company, said, "While our highest priority is to demonstrate cGMP compliance so we can return our approved products to market, we believe Gestiva(TM) will be an important addition to our women's health franchise and are pleased we could reach this agreement with Hologic. We will continue to assist Hologic in completing the steps to obtain FDA approval of this socially valuable product."

Source:

KV Pharmaceutical Company

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Hologic, Inc.. (2019, June 18). KV Pharmaceutical, Hologic amend Gestiva asset purchase agreement. News-Medical. Retrieved on February 03, 2023 from https://www.news-medical.net/news/20100112/KV-Pharmaceutical-Hologic-amend-Gestiva-asset-purchase-agreement.aspx.

  • MLA

    Hologic, Inc.. "KV Pharmaceutical, Hologic amend Gestiva asset purchase agreement". News-Medical. 03 February 2023. <https://www.news-medical.net/news/20100112/KV-Pharmaceutical-Hologic-amend-Gestiva-asset-purchase-agreement.aspx>.

  • Chicago

    Hologic, Inc.. "KV Pharmaceutical, Hologic amend Gestiva asset purchase agreement". News-Medical. https://www.news-medical.net/news/20100112/KV-Pharmaceutical-Hologic-amend-Gestiva-asset-purchase-agreement.aspx. (accessed February 03, 2023).

  • Harvard

    Hologic, Inc.. 2019. KV Pharmaceutical, Hologic amend Gestiva asset purchase agreement. News-Medical, viewed 03 February 2023, https://www.news-medical.net/news/20100112/KV-Pharmaceutical-Hologic-amend-Gestiva-asset-purchase-agreement.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
FDA clears Hologic's APTIMA Trichomonas vaginalis Assay